Pro- and anti-inflammatory response in neurological disorders associated to anti-glutamate decarboxylase antibodies.

J Neuroimmunol

Instituto Nacional de Neurología y Neurocirugía "Manuel Velasco Suárez", Insurgentes Sur 3877, La Fama, México City, 14269, México; Unit for the Study of Neuroinflamation in Neurological Diseases, Instituto de Investigaciones Biomédicas, UNAM, and Instituto Nacional de Neurología y Neurocirugía "Manuel Velasco Suárez", México City 14269, México. Electronic address:

Published: June 2021

Rare conditions showing psychiatric symptoms and movement disorders have been linked with the presence of anti-glutamate decarboxylase antibodies. Proinflammatory and antiinflammatory immune responses were assessed in patients with neurological disorders associated to anti-glutamic acid decarboxylase antibodies (NDGAD). Immunoregulatory and proinflammatory cell populations were quantified by flow cytometry. No polarization toward Th1, Th2, or Th17 phenotypes was observed in NDGAD patients. Immunoregulatory responses were significantly reduced for Breg, activated Treg, Tr1, and Th3 cells, suggesting a deficient regulatory response, while intermediate monocyte levels were increased. The reduced levels of regulatory T and B cells suggest an impairment in regulatory immune response, while intermediate monocytes could be playing a role in the increased proinflammatory response.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jneuroim.2021.577550DOI Listing

Publication Analysis

Top Keywords

decarboxylase antibodies
12
neurological disorders
8
disorders associated
8
anti-glutamate decarboxylase
8
response intermediate
8
pro- anti-inflammatory
4
response
4
anti-inflammatory response
4
response neurological
4
associated anti-glutamate
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!